NEW YORK (GenomeWeb) – Fluidigm reported after the close of the market on Thursday that its second quarter revenues grew 11 percent year over year, driven in part by strong sales of its mass cytometry instruments.

For the three months ended June 30, the South San Francisco, California-based life science research tools firm reported total revenues of $26.4 million compared to $23.9 million in the same quarter a year ago, in line with analysts' consensus estimate of $26.3 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.

The New York Times reports that evidence linking trauma in one generation to epigenetic effects that influence subsequent generations may be overstated.

ScienceInsider reports that US National Institutes of Health researchers were told in the fall they could not obtain new human fetal tissue.

In PNAS this week: skin pigmentation evolution among KhoeSan, biomarkers for dengue virus progression, and more.

Dec
12
Sponsored by
Illumina

This webinar will discuss the use of shotgun metagenomics to identify children at risk of hospital-acquired infection.